CECC offers more vaccine mixing options
The Central Epidemic Command Center (CECC) says it will be opening more Covid-19 vaccine mixing options by Friday.
This... after a government Advisory Committee met to discuss adjustments to the government's vaccine rollout programme.
The committee made several suggestions, including offering more vaccine mixing options... as well as giving extra jabs to people with weakened immune systems.
Those who have gotten a first dose of the AstraZeneca or Medigen jabs will be able to choose between the four brands on offer in Taiwan, as a second dose.
Those who have received either the Moderna or Pfizer-BioNTech vaccine will be given the same options.
Health officials say people will also be allowed to select one of the four jabs on offer for a booster, regardless of which vaccine brand they were given for their first two doses.
In other vaccine news, local vaccine developer, Adimmune, says it will launch clinical trials in Indonesia... for its Covid vaccine candidate by early next year.
Adimmune says it is looking to tap into the Muslim market with a halal certification.
Initial results of their tests are expected by mid-2022.
The Taichung-based company says it has modified the dose of its vaccine candidate... to ensure protection against coronavirus variants...
Phase 1 and 2 trials of its modified vaccine beginon 3 January.
A total of 240 people between the ages of 18 and 65 will be participating in the trials, which will be overseen by Indonesia's health regulator.
Adimmune's Phase 3 trials take place after the first two are completed. That is scheduled to have nearly 30,000 participants.